Categories: News

Neonode Announces Adjournment of Reconvened Annual Meeting of Stockholders

STOCKHOLM, June 25, 2024 /PRNewswire/ — Neonode Inc. (NASDAQ: NEON), announced today that its 2024 Annual Meeting of Stockholders (the “Annual Meeting”), which was reconvened to June 25, 2024, was called to order and again adjourned without any business being conducted due to a lack of the required quorum.

The Annual Meeting will reconvene on July 5, 2024 at 3:00 p.m. local time at Neonode’s principal executive office located at Karlavägen 100, 115 26 Stockholm, Sweden to provide its stockholders additional time to vote on the proposals described in the proxy statement filed with the Securities and Exchange Commission on April 26, 2024. No changes have been made in the proposals to be voted on by stockholders at the Annual Meeting.

The record date for determining stockholder eligibility to vote at the Annual Meeting will remain the close of business on April 22, 2024. Proxies previously submitted will be voted at the Annual Meeting unless properly revoked, and stockholders who have already submitted a proxy or otherwise voted need not take any action.

Neonode’s Board of Directors unanimously recommends that stockholders vote “FOR” all proposals and encourages all stockholders who have not already voted to do so immediately.

For more information or questions, please contact:

Interim President and Chief Executive Officer and Chief Financial Officer
Fredrik Nihlén
E-mail: fredrik.nihlen@neonode.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/neonode/r/neonode-announces-adjournment-of-reconvened-annual-meeting-of-stockholders,c4006459

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/neonode-announces-adjournment-of-reconvened-annual-meeting-of-stockholders-302182287.html

SOURCE Neonode

Staff

Recent Posts

Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024

FDA has Accepted for Review the Treosulfan NDAManagement to host conference call at 8:00 AM…

11 hours ago

Groundbreaking Ecosystem Map Reveals Innovative Collaborations, Care Pathways, and Technologies for Dementia

CHICAGO, June 25, 2024 /PRNewswire/ -- A new Journal of Alzheimer's Disease article unveils an…

11 hours ago

The Kevin Trudeau Show Expands to Twice Weekly Following a Much-Awaited Return

CHICAGO, June 25, 2024 /PRNewswire/ -- Following a triumphant return as a weekly broadcast, The…

11 hours ago

Adonis Raises $31 Million, Led by Point72 Private Investments, to Improve Healthcare Financial Outcomes and Patient Experiences Through AI

NEW YORK, June 25, 2024 /PRNewswire/ -- Adonis, a leading healthcare financial technology platform based…

11 hours ago

OBERD NAMED 2024 TECHNOLOGY VENDOR BY AAOS

COLUMBIA, Mo., June 25, 2024 /PRNewswire/ -- OBERD, the industry-leading patient-reported outcomes (PRO) vendor, has…

11 hours ago

Therap Services Unveils New Drug Count Module to Streamline Medications Management and Tracking in Healthcare Settings

TORRINGTON, Conn., June 25, 2024 /PRNewswire/ -- Therap Services, the leading provider of electronic health…

11 hours ago